A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this explorative trial is to collect preliminary data on efficacy and safety
of thymosin alpha 1 given at different doses as an adjuvant to egg-derived H1N1sw monovalent
influenza vaccine in hemodialysis patients. The final aim is that of gathering information
needed for planning a following confirmatory study on the efficacy and safety of Thymosin
alpha 1 in the same indication.